NF-κB and AP-1 connection: Mechanism of NF-κB-dependent regulation of AP-1 activity

Molecular and Cellular Biology

Volumn 24, Issue 17, 2004, Pages 7806-7819

  Fujioka, Shuichi ^a   Niu, Jiangong ^a,b   Schmidt, Christian ^a   Sclabas, Guido M ^a,c   Peng, Bailu ^a   Uwagawa, Tadashi ^a   Li, Zhongkui ^a   Evans, Douglas B ^a   Abbruzzese, James L ^a   Chiao, Paul J ^a,b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

^c UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SERUM RESPONSE FACTOR; TRANSCRIPTION FACTOR AP 1; CHUK PROTEIN, HUMAN; CHUK PROTEIN, MOUSE; DNA BINDING PROTEIN; DOXYCYCLINE; ELK1 PROTEIN, HUMAN; ELK1 PROTEIN, MOUSE; IKBKB PROTEIN, HUMAN; IKBKB PROTEIN, MOUSE; IKBKE PROTEIN, HUMAN; IKBKE PROTEIN, MOUSE; ONCOPROTEIN; PROTEIN C FOS; PROTEIN C JUN; PROTEIN SERINE THREONINE KINASE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELK 1; VASCULOTROPIN A;

ARTICLE; ELK1 GENE; FOSB GENE; FRA 1 GENE; FRA 2 GENE; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; JUNB GENE; JUND GENE; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; TRANSCRIPTION REGULATION; VEGF GENE; ANIMAL; CYTOLOGY; GENETICS; METABOLISM; MOUSE; MOUSE MUTANT; PHYSIOLOGY; PROMOTER REGION; SIGNAL TRANSDUCTION; STEM CELL; TUMOR CELL LINE;

CERVUS ELAPHUS; MURINAE;

ANIMALS; CELL LINE, TUMOR; DNA-BINDING PROTEINS; DOXYCYCLINE; ETS-DOMAIN PROTEIN ELK-1; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B KINASE; MICE; MICE, KNOCKOUT; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; STEM CELLS; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 4344660420     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.17.7806-7819.2004     Document Type: Article

References (86)

1. Abate, C., L. Patel, F. J. Rauscher III, and T. Curran. 1990. Redox regulation of fos and jun DNA-binding activity in vitro. Science 249:1157-1161.
2. Abo, A., E. Pick, A. Hall, N. Totty, C. G. Teahan, and A. W. Segal. 1991. Activation of the NADPH oxidase involves the small GTP-binding protein p21rac1. Nature 353:668-670.
3. Baeuerle, P. A., and D. Baltimore. 1988. Activation of DNA-binding activity in an apparently cytoplasmic precursor of the NF-kappa B transcription factor. Cell 53:211-217.
4. Baeuerle, P. A., and D. Baltimore. 1988. I kappa B: a specific inhibitor of the NF-kappa B transcription factor. Science 242:540-546.
5. Baldwin, A. S., Jr. 1996. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649-683.
6. Bancroft, C. C., Z. Chen, G. Dong, J. B. Sunwoo, N. Yeh, C. Park, and C. Van Waes. 2001. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways. Clin. Cancer Res. 7:435-442.
7. Brar, S. S., T. P. Kennedy, A. R. Whorton, T. M. Murphy, P. Chitano, and J. R. Hoidal. 1999. Requirement for reactive oxygen species in serum-induced and platelet-derived growth factor-induced growth of airway smooth muscle. J. Biol. Chem. 274:20017-20026.
8. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-1488.
9. Cavigelli, M., F. Dolfi, F. X. Claret, and M. Karin. 1995. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J. 14:5957-5964.
10. Collins, T. S., L. F. Lee, and J. P. Ting. 2000. Paclitaxel up-regulates interleukin-8 synthesis in human lung carcinoma through an NF-kappaB- and AP-1-dependent mechanism. Cancer Immunol. Immunother. 49:78-84.
11. Dalton, S., and R. Treisman. 1992. Characterization of SAP-1, a protein recruited by serum response factor to the c-fos serum response element. Cell 68:597-612.
12. Deacon, K., and J. L. Blank. 1999. MEK kinase 3 directly activates MKK6 and MKK7, specific activators of the p38 and c-Jun NH2-terminal kinases. J. Biol. Chem. 274:16604-16610.
13. Deng, Y., X. Ren, L. Yang, Y. Lin, and X. Wu. 2003. A JNK-dependent pathway is required for TNFalpha-induced apoptosis. Cell 115:61-70.
14. De Smaele, E., F. Zazzeroni, S. Papa, D. U. Nguyen, R. Jin, J. Jones, R. Cong, and G. Franzoso. 2001. Induction of gadd45beta by NF-kappaB down-regulates pro-apoptotic JNK signalling. Nature 414:308-313.
15. Devary, Y., C. Rosette, J. A. DiDonato, and M. Karin. 1993. NF-kappa B activation by ultraviolet light not dependent on a nuclear signal. Science 261:1442-1445.
16. Diekmann, D., A. Abo, C. Johnston, A. W. Segal, and A. Hall. 1994. Interaction of Rac with p67phox and regulation of phagocytic NADPH oxidase activity. Science 265:531-533.
17. Dong, Q. G., G. M. Sclabas, S. Fujioka, C. Schmidt, B. Peng, T. Wu, M. S. Tsao, D. B. Evans, J. L. Abbruzzese, T. J. McDonnell, and P. J. Chiao. 2002. The function of multiple IkappaB:NF-kappaB complexes in the resistance of cancer cells to Taxol-induced apoptosis. Oncogens 21:6510-6519.
18. Ellinger-Ziegelbauer, H., K. Brown, K. Kelly, and U. Siebenlist. 1997. Direct activation of the stress-activated protein kinase (SAPK) and extracellular signal-regulated protein kinase (ERK) pathways by an inducible mitogen-activated protein kinase/ERK kinase kinase 3 (MEKK) derivative. J. Biol. Chem. 272:2668-2674.
19. Fan, H., B. Sun, Q. Gu, A. Lafond-Walker, S. Cao, and L. C. Becker. 2002. Oxygen radicals trigger activation of NF-kappaB and AP-1 and upregulation of ICAM-1 in reperfused canine heart. Am. J. Physiol. Heart Circ. Physiol. 282:H1778-H1786.
20. Franzoso, G., L. Carlson, K. Brown, M. B. Daucher, P. Bressler, and U. Siebenlist. 1996. Activation of the serum response factor by p65/NF-kappaB. EMBO J. 15:3403-3412.
21. Frazier, M. L., E. Fernandez, R. de Llorens, N. M. Brown, S. Pathak. K. R. Cleary, J. L. Abbruzzese, K. Berry, M. Olive, A. Le Maistre, and D. B. Evans. 1996. Pancreatic adenocarcinoma cell line, MDAPanc-28, with features of both acinar and ductal cells. Int. J. Pancreatol. 19:31-38.
22. Fujioka, S., G. M. Sclabas, C. Schmidt, W. A. Frederick, Q. G. Dong, J. L. Abbruzzese, D. B. Evans, C. Baker, and P. J. Chiao. 2003. Function of nuclear factor kappaB in pancreatic cancer metastasis. Clin. Cancer Res. 9:346-354.
23. Fujioka, S., G. M. Sclabas, C. Schmidt, J. Niu, W. A. Frederick, Q. G. Dong, J. L. Abbruzzese, D. B. Evans, C. Baker, and P. J. Chiao. 2003. Inhibition of constitutive NF-kappaB activity by IkappaBalphaM suppresses tumorigenesis. Oncogene 22:1365-1370.
24. Garrido, C., S. Saule, and D. Gospodarowicz. 1993. Transcriptional regulation of vascular endothelial growth factor gene expression in ovarian bovine granulosa cells. Growth Factors 8:109-117.
25. Gille, H., M. Kortenjann, O. Thomae, C. Moomaw, C. Slaughter, M. H. Cobb, and P. E. Shaw. 1995. ERK phosphorylation potentiates Elk-1-mediated ternary complex formation and transactivation. EMBO J. 14:951-962.
26. Harwood, F. G., S. Kasibhatla, I. Petak, R. Vernes, D. R. Green, and J. A. Houghton. 2000. Regulation of FasL by NF-kappaB and AP-1 in Fas-dependent thymineless death of human colon carcinoma cells. J. Biol. Chem. 275:10023-10029.
27. Hipskind, R. A., D. Buscher, A. Nordheim, and M. Baccarini. 1994. Ras/MAP kinase-dependent and -independent signaling pathways target distinct ternary complex factors. Genes Dev. 8:1803-1816.
28. Hipskind, R. A., V. N. Rao, C. G. Mueller, E. S. Reddy, and A. Nordheim. 1991. Ets-related protein Elk-1 is homologous to the c-fos regulatory factor p62TCF. Nature 354:531-534.
29. Hodge, C., J. Liao, M. Stofega, K. Guan, C. Carter-Su, and J. Schwartz. 1998. Growth hormone stimulates phosphorylation and activation of elk-1 and expression of c-fos, egr-1, and junB through activation of extracellular signal-regulated kinases 1 and 2. J. Biol. Chem. 273:31327-31336.
30. Huang, S., C. A. Pettaway, H. Uehara, C. D. Bucana, and I. J. Fidler. 2001. Blockade of NF-kappaB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene 20:4188-4197.
31. Huang, S., J. B. Robinson, A. Deguzman, C. D. Bucana, and I. J. Fidler. 2000. Blockade of nuclear factor-kappaB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res. 60:5334-5339.
32. Hunt, K. K., J. B. Fleming, A. Abramian, L. Zhang, D. B. Evans, and P. J. Chiao. 1998. Overexpression of the tumor suppressor gene Smad4/DPC4 induces p21waf1 expression and growth inhibition in human carcinoma cells. Cancer Res. 58:5656-5661.
33. Janknecht, R., and A. Nordheim. 1992. Elk-1 protein domains required for direct and SRF-assisted DNA-binding. Nucleic Acids Res. 20:3317-3324.
34. Javelaud, D., and F. Besancon. 2001. NF-kappa B activation results in rapid inactivation of JNK in TNF alpha-treated Ewing sarcoma cells: a mechanism for the anti-apoptotic effect of NF-kappa B. Oncogene 20:4365-4372.
35. Karin, M. 1996. The regulation of AP-1 activity by mitogen-activated protein kinases. Philos. Trans. R. Soc. Lond. B Biol. Sci. 351:127-134.
36. Karin, M., and Y. Ben-Neriah. 2000. Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu. Rev. Immunol. 18:621-663.
37. Karin, M., T. Takahashi, P. Kapahi, M. Delhase, Y. Chen, C. Makris, D. Rothwarf, V. Baud, G. Natoli, F. Guido, and N. Li. 2001. Oxidative stress and gene expression: the AP-1 and NF-kappaB connections. Biofactors 15:87-89.
38. Kiriakidis, S., E. Andreakos, C. Monaco, B. Foxwell, M. Feldmann, and E. Paleolog. 2003. VEGF expression in human macrophages is NF-kappaB-dependent: studies using adenoviruses expressing the endogenous NF-kappaB inhibitor IkappaBalpha and a kinase-defective form of the IkappaB kinase 2. J. Cell Sci. 116:665-674.
39. Kroon, A. M., B. H. Dontje, M. Holtrop, and C. Van den Bogert. 1984. The mitochondrial genetic system as a target for chemotherapy: tetracyclines as cytostatics. Cancer Lett. 25:33-40.
40. Kroon, A. M., M. Holtrop, H. Fries, T. Melis, and C. van den Bogert. 1985. The effect of long-term inhibition of mitochondrial protein synthesis on the oxidation capacity of mitochondria for NADH-linked substrates. Biochem. Biophys. Res. Commun. 128:1190-1195.
41. Lakshminarayanan, V., E. A. Drab-Weiss, and K. A. Roebuck. 1998. H2O2 and tumor necrosis factor-alpha induce differential binding of the redox-responsive transcription factors AP-1 and NF-kappaB to the interleukin-8 promoter in endothelial and epithelial cells. J. Biol. Chem. 273:32670-32678.
42. Lee, F. S., J. Hagler, Z. J. Chen, and T. Maniatis. 1997. Activation of the IkappaB alpha kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88:213-222.
43. Lee, S. W., S. I. Han, H. H. Kim, and Z. H. Lee. 2002. TAK1-dependent activation of AP-1 and c-Jun N-terminal kinase by receptor activator of NF-kappaB. J. Biochem. Mol. Biol. 35:371-376.
44. Lehmann, U., P. Brocke, J. Dittmer, and A. Nordheim. 1999. Characterization of the human elk-1 promoter. Potential role of a downstream intronic sequence for elk-1 gene expression in monocytes. J. Biol. Chem. 274:1736-1744.
45. Li, Q., G. Estepa, S. Memet, A. Israel, and I. M. Verma. 2000. Complete lack of NF-kappaB activity in IKK1 and IKK2 double-deficient mice: additional defect in neurulation. Genes Dev. 14:1729-1733.
46. Li, Q., Q. Lu, J. Y. Hwang, D. Buscher, K. F. Lee, J. C. Izpisua-Belmonte, and I. M. Verma. 1999. IKK1-deficient mice exhibit abnormal development of skin and skeleton. Genes Dev. 13:1322-1328.
47. Li, Q., D. Van Antwerp, F. Mercurio, K. F. Lee, and I. M. Verma. 1999. Severe liver degeneration in mice lacking the IkappaB kinase 2 gene. Science 284:321-325.
48. Li, Q., and I. M. Verma. 2002. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2:725-734.
49. Marais, R., J. Wynne, and R. Treisman. 1993. The SRF accessory protein Elk-1 contains a growth factor-regulated transcriptional activation domain. Cell 73:381-393.
50. Montaner, S., R. Perona, L. Saniger, and J. C. Lacal. 1999. Activation of serum response factor by RhoA is mediated by the nuclear factor-kappaB and C/EBP transcription factors. J. Biol. Chem. 274:8506-8515.
51. Pahl, H. L. 1999. Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 18:6853-6866.
52. Papa, S., F. Zazzeroni, C. Bubici, S. Jayawardena, K. Alvarez, S. Matsuda, D. U. Nguyen, C. G. Pham, A. H. Nelsbach, T. Melis, E. D. Smaele, W. J. Tang, L. D'Adamio, and G. Franzoso. 2004. Gadd45 beta mediates the NF-kappa B suppression of JNK signalling by targeting MKK7/JNKK2. Nat. Cell Biol. 6:146-153.
53. Park, J. M., H. Brady, M. G. Ruocco, H. Sun, D. Williams, S. J. Lee, T. Kato, Jr., N. Richards, K. Chan, F. Mercurio, M. Karin, and S. A. Wasserman. 2004. Targeting of TAK1 by the NF-kappa B protein Relish regulates the JNK-mediated immune response in Drosophila. Genes Dev. 18:584-594.
54. Ransone, L. J., and I. M. Verma. 1990. Nuclear proto-oncogenes fos and jun. Annu. Rev. Cell Biol. 6:539-557.
55. Rao, V. N., and E. S. Reddy. 1994. elk-1 proteins interact with MAP kinases. Oncogene 9:1855-1860.
56. Salnikow, K., T. Kluz, M. Costa, D. Piquemal, Z. N. Demidenko, K. Xie, and M. V. Blagosklonny. 2002. The regulation of hypoxic genes by calcium involves c-Jun/AP-1, which cooperates with hypoxia-inducible factor 1 in response to hypoxia. Mol. Cell. Biol. 22:1734-1741.
57. Sassone-Corsi, P., and I. M. Verma. 1987. Modulation of c-fos gene transcription by negative and positive cellular factors. Nature 326:507-510.
58. Schmidt, C., B. Peng, Z. Li, G. M. Sclabas, S. Fujioka, J. Niu, M. Schmidt-Supprian, D. B. Evans, J. L. Abbruzzese, and P. J. Chiao. 2003. Mechanisms of proinflammatory cytokine-induced biphasic NF-kappaB activation. Mol. Cell 12:1287-1300.
59. Segal, A. W., and A. Abo. 1993. The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem. Sci. 18:43-47.
60. Sen, R., and D. Baltimore. 1986. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell 47:921-928.
61. Shao, N., Y. Chai, J. Q. Cui, N. Wang, K. Aysola, E. S. Reddy, and V. N. Rao. 1998. Induction of apoptosis by Elk-1 and deltaElk-1 proteins. Oncogene 17:527-532.
62. Shaulian, E., and M. Karin. 2002. AP-1 as a regulator of cell life and death. Nat. Cell Biol. 4:E131-E136.
63. Shibata, A., T. Nagaya, T. Imai, H. Funahashi, A. Nakao, and H. Seo. 2002. Inhibition of NF-kappaB activity decreases the VEGF mRNA expression in MDA-MB-231 breast cancer cells. Breast Cancer Res. Treat. 73:237-243.
64. Shih, S. C., and K. P. Claffey. 2001. Role of AP-1 and HIF-1 transcription factors in TGF-beta activation of VEGF expression. Growth Factors 19:19-34.
65. Shore, P., and A. D. Sharrocks. 1994. The transcription factors Elk-1 and serum response factor interact by direct protein-protein contacts mediated by a short region of Elk-1. Mol. Cell. Biol. 14:3283-3291.
66. Stein, B., A. S. Baldwin, Jr., D. W. Ballard, W. C. Greene, P. Angel, and P. Herrlich. 1993. Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J. 12:3879-3891.
67. Sulciner, D. J., K. Irani, Z.-X. Yu, V. J. Ferrans, P. Goldschmidt-Clermont, and T. Finkel. 1996. rac1 regulates a cytokine-stimulated, redox-dependent pathway necessary for NF-κB activation. Mol. Cell. Biol. 16:7115-7121.
68. Tang, G., Y. Minemoto, B. Dibling, N. H. Purcell, Z. Li, M. Karin, and A. Lin. 2001. Inhibition of JNK activation through NF-kappaB target genes. Nature 414:313-317.
69. Tapon, N., K. Nagata, N. Lamarche, and A. Hall. 1998. A new rac target POSH is an SH3-containing scaffold protein involved in the JNK and NF-kappaB signalling pathways. EMBO J. 17:1395-1404.
70. Tischer, E., R. Mitchell, T. Hartman, M. Silva, D. Gospodarowicz, J. C. Fiddes, and J. A. Abraham. 1991. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266:11947-11954.
71. Toledano, M. B., and W. J. Leonard. 1991. Modulation of transcription factor NF-kappa B binding activity by oxidation-reduction in vitro. Proc. Natl. Acad. Sci. USA 88:4328-4332.
72. Treisman, R. 1987. Identification and purification of a polypeptide that binds to the c-fos serum response element. EMBO J. 6:2711-2717.
73. Treisman, R., R. Marais, and J. Wynne. 1992. Spatial flexibility in ternary complexes between SRF and its accessory proteins. EMBO J. 11:4631-4640.
74. Vanhoutte, P., J. L. Nissen, B. Brugg, B. D. Gaspera, M. J. Besson, R. A. Hipskind, and J. Caboche. 2001. Opposing roles of Elk-1 and its brain-specific isoform, short Elk-1, in nerve growth factor-induced PC12 differentiation. J. Biol. Chem. 276:5189-5196.
75. Verger, A., and M. Duterque-Coquillaud. 2002. When Ets transcription factors meet their partners. Bioessays 24:362-370.
76. Verma, I. M., and P. Sassone-Corsi. 1987. Proto-oncogene fos: complex but versatile regulation. Cell 51:513-514.
77. Verma, I. M., J. K. Stevenson, E. M. Schwarz, D. Van Antwerp, and S. Miyamoto. 1995. Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev. 9:2723-2735.
78. von Knethen, A., D. Callsen, and B. Brune. 1999. NF-kappaB and AP-1 activation by nitric oxide attenuated apoptotic cell death in RAW 264.7 macrophages. Mol. Biol. Cell 10:361-372.
79. Wang, W., J. L. Abbruzzese, D. B. Evans, L. Larry, K. R. Cleary, and P. J. Chiao. 1999. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin. Cancer Res. 5:119-127.
80. Wang, Y., and R. Prywes. 2000. Activation of the c-fos enhancer by the erk MAP kinase pathway through two sequence elements: the c-fos AP-1 and p62TCF sites. Oncogene 19:1379-1385.
81. Xu, Z., N. V. Kukekov, and L. A. Greene. 2003. POSH acts as a scaffold for a multiprotein complex that mediates JNK activation in apoptosis. EMBO J. 22:252-261.
82. Yanagisawa, K., K. Tago, M. Hayakawa, M. Ohki, H. Iwahana, and S. Tominaga. 2003. A novel splice variant of mouse interleukin-1-receptor- associated kinase-1 (IRAK-1) activates nuclear factor-kappaB (NF-kappaB) and c-Jun N-terminal kinase (JNK). Biochem. J. 370:159-166.
83. Yang, J., Y. Lin, Z. Guo, J. Cheng, J. Huang, L. Deng, W. Liao, Z. Chen, Z. Liu, and B. Su. 2001. The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat. Immunol. 2:620-624.
84. Yasumoto, K., S. Okamoto, N. Mukaida, S. Murakami, M. Mai, and K. Matsushima. 1992. Tumor necrosis factor alpha and interferon gamma synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kB-like binding sites of the interleukin 8 gene. J. Biol. Chem. 267:22506-22511.
85. Yen, J., R. M. Wisdom, I. Tratner, and I. M. Verma. 1991. An alternative spliced form of FosB is a negative regulator of transcriptional activation and transformation by Fos proteins. Proc. Natl. Acad. Sci. USA 88:5077-5081.
86. Zhao, Q., and F. S. Lee. 1999. Mitogen-activated protein kinase/ERK kinase kinases 2 and 3 activate nuclear factor-kappaB through IkappaB kinase-alpha and IkappaB kinase-beta. J. Biol. Chem. 274:8355-8358.